NewGenIvf Group (NASDAQ:NIVF) Shares Scheduled to Reverse Split on Monday, January 26th

NewGenIvf Group Limited (NASDAQ:NIVFFree Report) shares are going to reverse split on Monday, January 26th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, January 25th.

NewGenIvf Group Price Performance

NIVF stock opened at $0.42 on Thursday. The business has a fifty day moving average price of $1.09 and a 200 day moving average price of $6.53. The company has a quick ratio of 3.37, a current ratio of 3.43 and a debt-to-equity ratio of 0.17. NewGenIvf Group has a fifty-two week low of $0.39 and a fifty-two week high of $1,422.50.

Analyst Ratings Changes

Several research analysts recently issued reports on NIVF shares. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, October 31st. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research note on Saturday, December 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on NIVF

About NewGenIvf Group

(Get Free Report)

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.

Further Reading

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.